中心離散性傷口脱毛症の治療におけるアプレミラスト:オープン試験
Journal of drugs in dermatology : JDD
|September 5, 2025
まとめ
Apremilastは,黒人女性における中心遠心性性脱毛症 (CCCA) の治療に適度な有効性と安全性を示しています. 患者は脱毛と生活の質の有意な改善を経験し,さらなる研究が必要でした.
科学分野:
- 皮膚科
- 臨床研究
- 薬理学について
背景:
- 中心離散性傷口脱毛症 (CCCA) は,黒人女性に影響を与える主要な傷口脱毛症である.
- 現在,CCCAの治療には標準的な治療法や承認された薬がない.
- 頂部が優勢であるCCCAは,特定の臨床的課題を提示します.
研究 の 目的:
- 軽度から中度まで,頂点に優勢なCCCAの治療におけるアプレミラストの有効性を調査する.
- CCCAに対するアプレミラスト治療の安全性と患者の報告した結果の評価.
主な方法:
- CCCAを患ったアフリカ系女性20人を対象とした単一センターのオープンラベル研究.
- 患者は24週間にわたってアプレミラスト30 mgを1日2回口服した.
- 医者と患者の総合的な評価,脱毛の重さ,,生活の質を評価した.
主要な成果:
- 20人の患者のうち15人が24週間の試験を終えた.
- 医者の総合評価 (P=0. 04),研究者全体の重症度 (P=0. 01),患者の総合評価 (P=0. 01) と (P=0. 00) で統計的に有意な改善が観察されました.
- 脱毛の重度 (P=0. 05) と皮膚科生活の質指数 (P=0. 09) の中等な改善が見られた.
結論:
- アプレミラストは中程度の有効性と,CCCA治療における良好な安全性プロファイルを示した.
- 患者の報告した結果の有意な改善は,潜在的な治療効果を示唆しています.
- 効果を確認し,CCCA管理におけるアプレミラストの役割を調査するために,より大きなプラセボ対照試験が推奨されます.
関連する概念動画
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
382
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
382
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
446
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
446
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
200
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
200
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
250
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
250
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
264
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
264
Drugs for Treatment of Ulcerative Colitis in IBD
236
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
236


